Архивъ внутренней медицины (Feb 2013)

ВЛИЯНИЕ ОМАКОРА НА ВАРИАБЕЛЬНОСТЬ СЕРДЕЧНОГО РИТМА И ИШЕМИЧЕСКИЕ ИЗМЕНЕНИЯ В МИОКАРДЕ У БОЛЬНЫХ ХРОНИЧЕСКОЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА В СОЧЕТАНИИ С САХАРНЫМ ДИАБЕТОМ 2 ТИПА

  • В. П. Михин,
  • Л. С. Мальцева

DOI
https://doi.org/10.20514/2226-6704-2013-0-1-25-32
Journal volume & issue
Vol. 0, no. 1
pp. 25 – 32

Abstract

Read online

We have studied effect of Omacor in the treatment of patients with chronic coronary heart disease (CHD) with diabetes mellitus (DM) type 2 on heart rate variability (HRV) and the severity of ischemic processes in myocardium. It is shown that Omacor taking (1 g/day) in the complex therapy for 3 months leads to improvement of HRV (time and frequency), with more pronounced positive effect in patients without postinfarction cardiosclerosis. Admission of Omacor increases antianginal effects of nitrates and beta-blockers, reduces necessity of using a short-acting nitrates to relieve angina. It allows to recommend to include Omacor in complex treatment of patients with chronic CHD and type 2 DM in order to improve HRV, as well as improving the effectiveness of key antianginal agents.

Keywords